Lv3
280 积分 2023-01-29 加入
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
2天前
已完结
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia
14天前
已完结
Regulatory, product development, resources, and financial challenges associated with creating and commercializing combination products
4个月前
已关闭
Moving toward Meaningful Standards for Preclinical Performance Testing of Medical Devices and Combination Products with Antimicrobial Effects
4个月前
已完结
Moving toward Meaningful Standards for Preclinical Performance Testing of Medical Devices and Combination Products with Antimicrobial Effects
4个月前
已关闭
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
5个月前
已完结
PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program
5个月前
已完结
Bempeg Failure Unlikely to Affect Other IL2 Drugs
5个月前
已完结
Interleukin-2–based therapies in cancer
5个月前
已完结
Interleukin-2 and regulatory T cells in rheumatic diseases
5个月前
已完结
皖公网安备34019202002308
